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Abstract
Background: To identify through the scientific literature, the risk fac-
tors of the nursing diagnosis “risk of infection” in studies conducted 
in hospitalized cancer patients.
Method: This is an integrative literature review performed in da-
tabases Latin American Literature in Health Sciences; PubMedCen-
tral, Cumulative Index toNursingandAllied Health Literature; Medical 
LiteratureAnalysis and Retrieval System Online; Scopus Info Site; Web 
of Science; Nursing Databases; and Bibliographical Index Español de 
Ciencias de la Salud in January 2016, using the keywords of Health 
Sciences and Medical Subject Headings: (Neoplasms OR Cancer), 
"Cross Infection", "Risk Factors". Inclusion criteria were scientific ar-
ticles available in full, with results of at least one risk factor for the 
nursing diagnosis studied in patients aged 18 years of age or older. 
After the analysis, the final sample consisted of 59 articles.
Results: Predominated studies outside Brazil with the level of eviden-
ce III.2. Out of 19 risk factors for diagnosis, 11 were identified in the 
literature for this population.
Conclusion: In studies of hospitalized cancer population, risk factors 
of nursing diagnosis “risk of infection” were found.
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Introduction
Cancer is a major cause of mortality worldwide with approximately 14 
million new cases and 8.2 million related deaths in 2012. The prospect 
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is that in two decades, the number of new cases 
disease reaches 22 million. [1]
Infections related to health care are the most 
common adverse events in the provision of health 
care around the world and represent a significant 
cause of morbidity and mortality. The high frequen-
cy of this event is directly associated with the use 
of invasive devices and procedures, and inversely to 
the income of countries and conditions of health 
infrastructure. [2]
Oncologic patients are especially susceptible to 
infections related to healthcare for two main rea-
sons: the first one, by the physiological manifesta-
tions of the disease culminating in depletion of cell 
and humoral function of the immune system, and 
immunosuppression caused by cytotoxic chemothe-
rapy treatment. The second one, because patients 
are exposed to potentially pathogenic microorga-
nisms in treatment. As a result of the environment, 
there is an increased length of hospital stay, com-
plications, and deaths among those who developed 
infections compared to those who did not develop 
infections. [3]
Among the risk factors related to the develop-
ment of hospital infections in oncology patients, 
there is age, presence of comorbidities, especially 
hypertension, diabetes mellitus and smoking; the 
hospitalization; and invasive procedures. Hospital in-
fection is associated with higher rates of mortality 
in patients undergoing cancer therapies. [4]
The nursing staff conceives a body of professio-
nals who perform therapeutic actions and comfort 
to these patients and the proper attribution is clo-
ser, being directly responsible for the care. Such care 
is a set of efforts aimed at human beings, in which 
it is up to the nursing staff to cope with the disease 
in which there is a demand for prolonged treatment 
and management of expected adverse effects. [5]
The systematization of Nursing care organizes 
professional work on the method, personnel, and 
instruments, enabling the implementation of the 
nursing process (NP). This NP allows nurses to iden-
tify, understand, describe, intervene, resolve and 
achieve results before the health problems. Given 
this, the Nursing Diagnosis (ND) becomes inserted 
into this NP. [6]
The use of nursing diagnosis risk of infection as 
the first stage of the nursing process is justified by 
the need to identify risk factors, which the patients 
are submitted and then a directed care plan ela-
borated to reduce the development of this adverse 
event.
Given the above, the aim of this study is to identi-
fy the literature of the risk factors nursing diagnosis 
“risk of infection” in studies conducted with hospi-
talized oncologic patients.
Methodology
This is an integrative literature review method that 
has the purpose of analysis and synthesis of various 
independent studies addressing the same subject, in 
an organized and orderly manner, to support critical 
thinking and improvements in clinical practice. [7]
Therefore, six stages were used consisting of ela-
boration of the guiding question; search or sampling 
in the literature; data collection; critical analysis of 
the included studies; discussion of the results; and 
presentation of the integrative review. In this study, 
the guiding question was: what are the risk factors 
related to the nursing diagnosis "risk of infection" 
in hospitalized people with cancer found in the li-
terature? [7]
The following inclusion criteria were adopted: 
1. scientific articles available in full; 2. Studies with 
patients aged 18 years of age or older; 3. Studies 
presenting at least one defining characteristic of 
nursing diagnosis studied in the results. The studies 
in editorial format, letter to the editor and literature 
review were excluded.
The searches were conducted from January 19 
to 30, 2016 in the databases and virtual libraries: 
Latin American Literature in Health Sciences; Pub-
Med Central, Cumulative Index to Nursing and 
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Allied Health Literature; Medical Literature Analysis 
and Retrieval System Online; Scopus Info Site; Web 
of Science; Nursing Databases; and Bibliographical 
Index Español de Ciencias la Salud.
Using keywords in Health Sciences (DeCS) and 
Medical Subject Headings (MeSH): (Neoplasms OR 
Cancer)/(Neoplasms OR Cancer), "Infection"/"Cross 
Infection", Risk Factors/"Risk Factors" by the ope-
rator Boolean AND. In SCOPUS, the search was 
conducted in a controlled manner by the excessi-
ve number of articles found while in the other the 
search was not controlled.
The choice of the keywords was due to the ab-
sence of the descriptor “risk of infection” in the 
nomenclature DeCS/MeSH and the lack of studies 
that addressed risk factors for nosocomial infection 
development when using the descriptor “nursing 
diagnosis” at intersections.
The study selection procedure was performed 
by peers, independently from a data collection ins-
trument created by the authors, containing the fo-
llowing information: author/year basis, title, journal, 
the reference level of evidence and risk factor. La-
ter, there was a meeting to define the articles that 
would be selected to compose the study, based on 
the consensus between the pair.
For the selection of studies, the PRISMA recom-
mendations were used [8], as shown in Figure 1. 
With the application of the study descriptors, the-
re were 640 articles found in the eight surveyed 
databases. After analyzing all the bases and their 
respective intersections, 22 articles were counted 
only once for being duplicated. Then, there was the 
reading of titles and abstracts, selecting 155 studies 
considered potentially relevant. After the review, 95 
studies were selected for reading in full. After the 
full-text reading of the articles, it was found that 
59 articles responded to the objective of this study 
and were included in the final sample of the review, 
two of LILACS, three of CINAHL, seven of MEDLINE, 
thirty-nine of SCOPUS and eight of PUBMED (Figure 
1) (Table 1).
The selected articles were classified according to 
level of evidence adopting as a parameter of the 
Institute Joanna Briggs, which employs a compound 
classification system of four levels, "Level I: Eviden-
ce obtained from a systematic review containing 
only randomized controlled trials; Level II: Evidence 
obtained from at least one randomized controlled 
trial; Level III.1: Evidence obtained from well-desig-
ned controlled trials without randomization; Level 
III.2: Evidence obtained from well-designed cohort 
studies or case-control analytic studies, preferably 
Figure 1:  Articles selection flowchart for integrative 
literature review, prepared from PRISMA 
recommendations [7]. Natal/RN, 2016.
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Table 1.  Distribution of the domains and facets of QoL. João Pessoa, PB, 2015.
Databases Search strategy F D AT AF S
Lilacs (Neoplasias OR Câncer) AND “Infecção Hospitalar” AND “Fatores de Risco.” 14 2 5 4 2
Cinahl (Neoplasms OR Cancer) AND "Cross Infection" AND "Risk Factors" 54 0 8 4 3
Medline (Neoplasias OR Câncer) AND “Infecção Hospitalar” AND “Fatores de Risco.” 207 3 47 17 7
Scopus KEY (Neoplasms OR Cancer) AND "Cross Infection" AND "Risk Factors" 282 5 58 53 39
Pubmed (Neoplasms OR Cancer) AND "Cross Infection" AND "Risk Factors" 69 12 31 12 8
Web ofscience (Neoplasms OR Cancer) AND "Cross Infection" AND "Risk Factors" 9 0 5 5 0
Bdenf (Neoplasias OR Câncer) AND “Infecção Hospitalar” AND “Fatores de Risco.” 3 0 1 0 0
Ibecs (Neoplasias OR Câncer) AND “Infecção Hospitalar” AND “Fatores de risco” 2 0 0 0 0
Total 640 22 155 95 59
*F: Found. **D: Duplicated. ***AT: Abstract title.****AF: Analysis in full. *****S: Selected
Table 2.  Risk factors for the development of noso-
comial infection identified in patients hos-
pitalized with cancer. Natal/RN, 2016.
N (%)
Inadequate primary defenses
Change in skin integrity (invasive 
procedures) [10, 11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 22]
35 (59.3%)
Changing the peristalsis [23, 24, 25, 26, 27, 
28]
4 (6.8%)
Smoking [23, 29, 30, 31] 4 (6.8%)
Inadequate secondary defenses
Leukopenia [19, 24, 25, 26, 29, 32, 33, 34, 
35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 
57, 58]
25 (4.2%)
Immunosuppression [23, 25, 29, 40, 43, 53, 
54, 59]
11 (18.6%)
Haemoglobin decrease [10, 21, 23, 39] 2 (3.4%)
Malnutrition 
Severe malnutrition [31, 60] 2 (3.4%)
Chronic disease
Diabetes [10, 12, 16, 17, 23, 26, 31, 32, 37, 
43, 45, 59, 61, 60, 62]
16 (27.1%)
Chronic Kidney feilure [12, 16, 25, 26, 32, 
37, 43, 59, 63, 62]
10 (16.9%)
Hypertension [23, 31, 32, 37, 43, 59, 61] 3 (5%)
Obesity [10, 23, 62] 3 (5%)
from more than one center or research group; III. 3 
Level: Evidence obtained from multiple time series 
with or without intervention and dramatic results 
in uncontrolled experiments; Level IV Opinion of 
respected authorities based on clinical criteria and 
experience, descriptive studies or expert committee 
reports. As for the ethical aspects of the studies, 
of all articles studied respected the authorship. [9]
The presentation of results and discussion of the 
data occurred in a descriptive way, by providing the 
applicability of the review elaborated and provide 
grants to nurses on the use of nursing diagnosis in 
this population.
Results
This study analyzed 59 articles that met the pro-
posed theme. Studies with evidence level III. 2 pre-
dominated, which corresponds to the Evidence ob-
tained from well-designed cohort studies or case-
control analytic studies. As the year of publication, 
studies have ranged between 1988 and 2015, with 
27 articles (45.8%) in the last five years.
Out of the articles analyzed, it was observed that 
most articles come from outside Brazil, with good 
indexing and evaluation of high quality for nursing. 
Five articles were published in Brazilian journals, 
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three of them in The Brazilian Journal of Infectious 
Diseases. As to the place of study and language, 
three studies were conducted in Brazil, one in the 
state of Rio de Janeiro [10] and two in São Paulo. 
[11, 12] Only one of them was presented in Portu-
guese.
Risk factors for infection risk nursing diagnosis to 
cancer patients at risk of hospital infections addres-
sed in articles were grouped in defense inadequate 
primary categories, inadequate secondary defenses, 
malnutrition and chronic disease, and are listed in 
Table 2, respectively, according to the frequency 
with which they were found in studies.
Discussion
From the selected studies, there was a predomi-
nance of evidence presented in III. 2 level obtained 
from well-designed cohort studies or case-control 
analytic studies, implying the recommendations of 
the best results for application in professional prac-
tice mainly in the choice of assessment instruments 
and intervention proposals for the control of risk 
factors for infection. However, it is noteworthy the 
lack of randomized clinical trial having as focus the 
nursing care and the risk of infection in this popu-
lation.
As for risk factors defenses, inadequate primary 
for cancer patients at risk of nosocomial infection 
stands out the invasive procedure which was pre-
sent in 35 articles. Of them, 19 articles addressed 
the central venous catheter (CVC) as a risk factor, 
while the surgical procedure was listed in eighteen 
studies.
Intravenous catheters have brought great benefits 
to the treatment and control of disease symptoms, 
besides being used as parenteral feeding route in 
case of impossibility of enteral nutrition. However, 
studies point out that these pathways ultimately es-
tablish direct contact between the external environ-
ment and the bloodstream and thus increasing the 
likelihood of bloodstream infection development 
that can progress to sepsis with severe consequen-
ces. [65, 66]
Moreover, these accesses act as a foreign body, 
causing inflammation at the insertion site, resul-
ting in decreasing of local anti-infection defense, 
allowing infections are established from small inocu-
lants. Thus, every effort should be effect to prevent 
the development of this event which is a predictor 
of increased morbidity and mortality in this patients. 
[67]
During the hospitalization in oncology units, 
intravenous therapy is necessary at all stages of 
treatment, requiring venous access with good con-
ditions of infusion medications, hydration, exams 
collection, and nutrition. These needs are met with 
the viability of central venous catheters, particularly 
of long-term, mainly used in antineoplastic che-
motherapy administration. The increased exposure 
of this population to this type of catheterization 
makes them more vuleráveis the development of 
bloodstream infections related to these devices. [68]
A study in Japan studied the economic effect 
of infections related to central venous catheters 
and identified a substantial additional cost for the 
treatment of these infections, which include medi-
cations and medical supplies, and fees techniques. 
[69]
American study evaluated complications and 
postoperative mortality in a population with can-
cer, and the local surgical infection was the second 
more frequent complication. [70] This is a serious 
problem of hospital infections, for its incidence, 
morbidity, mortality, and financial costs. According 
to the Center for Disease Control (CDC), the fac-
tors supporting the occurrence of ISC are related to 
the patient, the surgical procedure, and the micro-
organism. [71]
Other factors favor and increase the risk infection 
related to the surgical place to undergo chemothe-
rapy or radiotherapy before surgery. The radiothe-
rapy causes a variety of tissue damage and vas-
cular lesions leading to ischemia and compromises 
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the venous return and lymphatic drainage reducing 
the oxygen supply to tissue irradiated and therefo-
re local defenses [72].Chemotherapy decreases the 
proliferation of rapidly growing cells such as blood 
responsible for immunity, and the cells of body tis-
sues, including their skin, complicating the healing 
process. [73]
Also regarding to inadequate primary defenses, 
inadequate peristalsis was found in our study in 
the occurrence of diarrhea among patients in the 
sample and stands out as a facilitator of infections 
development during its occurrence, the pathogens 
promote the synthesis and cytokine liberation which 
increases the inflammatory cascade, and aggrava-
te epithelial injury through the release of reactive 
oxygen species, leading to inflammatory segrega-
tion. [74]
As for the inappropriate peristalsis listed as a risk 
factor by NANDA, it is known that the intestine 
actively participates in protecting the body against 
infection, since it is responsible for the synthesis 
of substrates used as harmful microorganisms ba-
rrier. Instability caused by episodes of diarrhea is 
responsible for the death of enterocytes, damaging 
the digestive, absorptive and protective capabilities 
allowing the flow of toxins through the intestine, 
which may relate to including a larger load infection 
and further damage to the ileum. [75]
As for smoking, this generates systemic and local 
changes, which strongly affect the respiratory tract, 
affecting the immune response, mechanical barrier 
of the respiratory system and mucociliary transport 
which is considered an important defense mecha-
nism of the respiratory tract because it imprisons 
and expels the aggressors’ agents. The nicotine and 
other compounds present in the smoke have a sup-
pressive effect on the immune system, which ex-
plains the increase in respiratory tract infection. [76]
Regarding leukopenia, medicines used to combat 
the sick cells and also destroy some of the healthy 
cells of the body. Bone marrow cells are quite sus-
ceptible to aggression caused by chemotherapeutic 
agents. As a result, leukocytes can be interfered 
with their production, in their fall determining blood 
counts. Among leukocytes, neutrophils are, in most 
cases, the front line of defense of the body. For this 
reason, when they are too low, the risk of infection 
is higher. [77]
Concerning risk factors inadequate defenses se-
condary, immune-suppression was found in a sig-
nificant portion of the study. This can be caused 
by extensive use of immune-suppressive agents and 
glucocorticoids used in treatment antineoplastic 
and the use of antibiotics as influencers of immune-
suppression. Glucocorticoids induce an increase in 
white blood cells and lymphopenia to compromise 
the growth, differentiation and lymphocyte proli-
feration by a decrease in Interleukin [2], affecting 
T-lymphocytes predominantly. Thus, the prolonged 
use of glucocorticoids enables the appearance of 
fungus infections, bacteria, and viruses that may 
generate severe disseminated infections. [78]
Indiscriminate use of antibiotics triggers and acce-
lerates the defense mechanisms of bacteria, which 
by genetic mutations, they develop a resistance to 
these drugs, reducing their efficiency. This problem 
becomes relevant to public health since these drugs 
resistance happens at higher speeds than the deve-
lopment of new drugs. [79]
As regards the risk factor reduction in hemog-
lobin concentration, this is considered to be one 
factor that impairs the transport of oxygen to the 
tissues, chronic blood causing chronic blood loss, 
skin, and mucosal changes, gastrointestinal distur-
bances, weakness, palpitation, followed by infec-
tious processes or prolonged inflammatory. [80]
As to malnutrition risk factor, this enables a wide 
variety of infectious diseases. The response of the 
immune system depends on cell replication and 
synthesis of protein active compounds, and this 
process dependent on nutritional status. Calories, 
amino acids, and fat-soluble vitamins are nutrients 
for which reduced availability causes a deficit in the 
immune system, such as decreased of humoral an-
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tibodies and the surface of mucosal cell-mediated 
immunity, the bactericidal activity of phagocytes, 
among others. [81]
Concerning the chronic disease risk factor, studies 
highlight the bloodstream infection may also be due 
to the immune suppression associated with hyper-
glycemia direct consequence of diabetes. For this 
significantly decreases the function of neutrophils 
and monocytes through chemotaxis, and interfere 
with the phagocytic, and bactericidal function. [82, 
83] 
In chronic kidney disease and hypertension leads 
to tissue injury that carries on an ongoing immune 
stimulation. This favors the complete tissue des-
truction, installation, and disease progression. The 
persistent glomerular injury produces capillary pres-
sure, increased glomerular filtration, and passage of 
proteins into the tubular fluid; glomerular origin of 
proteinuria increases the production of angiotensin 
II and promotes the release of inflammatory media-
tors, the cytokines. [84]
About obesity risk factor, excess adipose tissue 
enhances the formation of adipokines promoting 
negative impact on certain bodily functions, inclu-
ding the response of the immune system. The adi-
pocytes secrete cytokines that allow the release of 
factors related to inflammation. [85]
Conclusion
After analysis of the studies, it was found that the 
nursing diagnosis "risk of infection" can be identi-
fied in cancer patients because of the risk factors 
listed 19 by NANDA, 11 have been identified in the 
literature for this population. The most common risk 
factors found in the results were "change in skin 
integrity" and "chronic disease," respectively.
The identification of risk factors for the deve-
lopment of infection in hospitalized patients with 
cancer is an essential activity for the monitoring 
of a committed nursing to quality of care and the 
possibility of minimizing adverse events related to 
health assistance. Thus, developed nursing care 
enables accurate monitoring of risk factors and early 
intervention for those controllable factors to mini-
mize infections and reduce morbidity and mortality 
associated with them.
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